ValiRx Plc

Type: Company
Name: ValiRx Plc
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Upgrade hints at ValiRx's significant potential

The City broker Daniel Stewart has lifted its valuation on drug developer ValiRx ( LON:VAL ) following the recent acquisition of VAL401, a clinical-stage potential treatment for lung cancer. Repeating his ‘buy’ advice, analyst Vadim Alexandre raised ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 14 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

ValiRx Plc Rating Reiterated by Daniel Stewart & Co (VAL)

Shares of ValiRx Plc (LON:VAL) traded down 3.73% on Tuesday, hitting GBX 0.284. The stock had a trading volume of 34,059,400 shares. ValiRx Plc has a 52-week low of GBX 0.28 and a 52-week high of GBX 0.55. The stock has a 50-day moving average of GBX ... [Published American Banking News - Forex - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 3 reports

Proactive news summary: InternetQ, AdEPT Telecom, ValiRx, Ncondezi Energy, Gemfields, ANGLE

Mobile marketing specialist InternetQ ( LON:INTQ ) had its target price hiked by Canaccord Genuity on Tuesday after impressive full-year figures. Adjusted EBITDA rose by a third to €16.2mln in 2013 from €12.2mln the year before on the back of a 42% ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 10 reports

UPDATE ValiRx sets up joint venture to advance lung cancer drug

---adds broker comment and share price---ValiRx (LON:VAL) has set up a joint venture firm with Tangent Reprofiling to advance a treatment for lung cancer, for which the market is valued at around US$5 billion.ValiSeek has purchased the exclusive wo.. ... [Published BioPortfolio - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 2 reports

Most followed: AFC Energy, Advanced Comp, Barclays, Falkland Islands, Motive TV, Quindell, ValiRx

Aside from the latest twist in the LIBOR saga involving Barclays ( LON:BARC ), news on the blue-chips is sparse today. That leaves the stage open for the growth stocks, and one of the hottest stories of the morning has been the joint venture announced ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 2 reports

Market report: Major placings

Two significant stakes in plc companies have been sold. Retail powerhouse Sports Direct International ( SPD ) cheapens 6.3% to 837.5p after owner Mike Ashley surprises the City by selling over £200 million worth of shares at 850p just days after a row ... [Published Shares Magazine - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 2 reports

Proactive Invs UK Ld : Innovation Forum

Innovation Forum, Thursday April 10.Proactive Investors, the international financial news provider to one of the world's largest communities of sophisticated investors, is pleased to unveil the line-up for the London Innovation Forum on Thursday (April ... [Published Investegate - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 3 reports

ValiRx in risk-sharing JV with Tangent Reprofiling Ltd

StockMarketWire.com - ValiRx Plc, the life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, has established ValiSeek Limited, a risk-sharing JV company with Tangent Reprofiling Limited. ValiSeek has acquired ... [Published Stock Market Wire - Apr 08 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 2 reports

Q&A ValiRx looks forward to clinical trials

Related Biotechnology, Pharmaceutical and Healthcare NewsProactive Investors (PI) interviewed the management of the cancer drug treatment developer to find out about future plans.Original Article: Q&A: ValiRx looks forward to clinical trialsNEXT ARTICLE ... [Published BioPortfolio - Apr 01 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 6 reports

VALIRX : Anti-Cancer Compound To Undergo Further Study

LONDON ( Alliance News ) - ValiRx PLC said Tuesday that its clinical trial project team for its anti-cancer compound VAL201 has recommended a further stability and sterility study to allow for the acceleration towards a Phase 2 efficacy study.ValiRx said ... [Published 4 Traders - Apr 01 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

ValiRx PLC : Posting of R&As and Notice of AGM

ValiRx Plc("ValiRx" or "the Company")Posting of Annual Report and Accounts Notice of Annual General MeetingValiRx Plc (AIM: VAL), the life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announcesThe Company ... [Published Investegate - Mar 28 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

ValiRx says annual results show the company is 'making progress'

George Morris, chief operating officer of ValiRx ( LON:VAL ) tells Proactiveinvestors the company's annual results show the company is 'making progress'. ... [Published Proactiveinvestors United Kingdom website - Mar 26 2014]
Entities: ValiRx Plc

Quotes

NEXT ARTICLE More From BioPortfolio on "UPDATE - ValiRx sets up joint venture to advance lung cancercancer drug"
Dr Satu Vainikka, ValiRx chief executive, said on Tuesday: "We are delighted to have the opportunity to further strengthen our oncology therapeutic portfolio with a project of great potential in an area of such unmet medical need and I'm delighted to have Suzy coming on board to run ValiSeek, which will provide the group with extra resource and experience."
NEXT ARTICLE More From BioPortfolio on "UK’s ValiRx forms joint venture to fast track lung cancercancer drug to Phase II"
...NetPlay details way in which it will reduce the financial impact but it clearly didn "t install enough confidence in the market."

More Content

All (76) | News (74) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Upgrade hints at ValiRx's significant potential [Published Proactiveinvestors United Kingdom RSS feed - Apr 14 2014]
AIM : AIM Notice - 11/04/2014 [Published Investegate - Apr 11 2014]
ValiRx Plc Rating Reiterated by Daniel Stewart ... [Published American Banking News - Forex - Apr 08 2014]
Proactive news summary: InternetQ, AdEPT Teleco... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
UPDATE ValiRx sets up joint venture to advance... [Published BioPortfolio - Apr 08 2014]
UPDATE - ValiRx sets up joint venture to advanc... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
Most followed: AFC Energy, Advanced Comp, Barcl... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
UK’s ValiRx forms joint venture to fast track l... [Published Pharma Letter - Apr 08 2014]
Market report: Major placings [Published Shares Magazine - Apr 08 2014]
UKs ValiRx forms joint venture to fast track lu... [Published BioPortfolio - Apr 08 2014]
ValiRx unveils JV with Tangent Reprofiling [Published PredictWallStreet - Apr 08 2014]
ValirX : In Joint Venture With Tangent Reprofil... [Published 4 Traders - Apr 08 2014]
FTSE down on Wall St pall, financial stocks suffer [Published MoneyAM - Apr 08 2014]
Most followed: AFC Energy, Advanced Comp, Barcl... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
Proactive Invs UK Ld : Innovation Forum [Published Investegate - Apr 08 2014]
Tuesday's most followed including Sports Direct... [Published Proactive Investors.co.uk - Apr 08 2014]
Innovation Forum [Published TrustNet - Apr 08 2014]
Market movers including Sports Direct, ValiRx, ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
ValiRx Plc establishes joint venture company [Published Reuters - Apr 08 2014]
ValiRx sets up joint venture to advance lung ca... [Published Proactive Investors.co.uk - Apr 08 2014]
ValiRx sets up joint venture to advance lung ca... [Published Proactiveinvestors United Kingdom website - Apr 08 2014]
ValiRx in risk-sharing JV with Tangent Reprofil... [Published Stock Market Wire - Apr 08 2014]
ValiRx sets up joint venture to advance lung ca... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
FLASH: ValiRx in risk-sharing JV with Tangent R... [Published Stock Market Wire - Apr 08 2014]
ValiRx in risk-sharing JV with Tangent Reprofiling [Published Telegraph - Apr 08 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
FTSE gains get Wall St boost, with insurers cli... [Published Stock Market Wire - Apr 01 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ValiRx sets up joint venture to advance lung ca... [Published Proactiveinvestors United Kingdom website - Apr 08 2014]
ValiRx ( LON:VAL ) has set up a joint venture firm with Tangent Reprofiling Ltd to advance a treatment for lung cancer, for which the market is valued at around US$5 billion. ValiSeek has purchased the exclusive worldwide licence for the drug VAL401 ...
ValiRx says annual results show the company is ... [Published Proactiveinvestors United Kingdom website - Mar 26 2014]
George Morris, chief operating officer of ValiRx ( LON:VAL ) tells Proactiveinvestors the company's annual results show the company is 'making progress'. ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.